BioLineRx (BLRX) Reports In-Line Q1 EPS

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of $0.00. Revenue for the quarter came in at $480 thousand.

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• ASM International NV (ASM:NA) PT Raised to EUR1,174 at JPMorgan
• SanDisk and Micron surge as Apple confirms memory price pass-through